NCT01935674View on ClinicalTrials.gov

Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels

PHASE4CompletedINTERVENTIONAL
Enrollment

43

Participants

Timeline

Start Date

September 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
HIVHypercholesterolaemia
Interventions
DRUG

Switch ritonavir-boosted PI

Switch their existing ritonavir-boosted PI to another potent ART drug with lesser effects on serum cholesterol selected by the investigator.

DRUG

Continue Ritonavir-boosted PI+Rosuvastatin

Continue ritonavir-boosted PI-based ART and commence rosuvastatin 10 mg daily (5 mg daily in Asian participants).

Trial Locations (1)

08036

Hospital Clinic of Barcelona, Barcelona

All Listed Sponsors
lead

Juan A. Arnaiz

OTHER

NCT01935674 - Treatment With Rosuvastatin Versus Switching PI (Protease Inhibitor) in Patients HIV With High Cholesterol Levels | Biotech Hunter | Biotech Hunter